U.S. federal trademark · Serial No. 88564765 · Reg. No. 6198088
Pharmaceutical research services in connection with identifying genes and biomarkers relevant for cancer; Pharmaceutical research and development services; research and development services in the field of diagnostic tools and tests for identifying patients with genetic mutations or biomarkers relevant to oncology treatment
Source: USPTO federal trademark records. Informational only, not legal advice. Status and details may lag the live USPTO database.